{"id":"W4404455104","doi":"10.25251/skin.8.supp.423","title":"Deucravacitinib in Plaque Psoriasis: 4-year Safety and Efficacy Results from the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials","year":2024,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"National Institute for Health and Care Research; Manchester Biomedical Research Centre; Bristol-Myers Squibb","keywords":"Plaque psoriasis; Psoriasis; Medicine; Phase (matter); Dermatology; Computer science; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004569717,0.000864051,0.001223071,0.0003487129,0.0004355311,0.001225542,0.0004962653,0.0009638875,0.001558991],"category_scores_gemma":[0.002585,0.0002661617,0.002183678,0.0003532062,0.0003426057,0.0009164551,0.0003823819,0.002004867,0.0004143369],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000707677,"about_ca_system_score_gemma":0.0008340374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008137813,"about_ca_topic_score_gemma":0.001826305,"domain_scores_codex":[0.9987102,0.0005775205,0.000116267,0.0001839389,0.0002410549,0.0001709303],"domain_scores_gemma":[0.9979138,0.0004630234,0.0007197068,0.0002315031,0.0002740908,0.0003978778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.570882,0.01652075,0.05849129,0.002538659,0.01238091,0.0003762327,0.0004971157,0.006931296,0.02771533,0.0004077352,0.01233683,0.2909218],"study_design_scores_gemma":[0.3154358,0.2982828,0.3336357,0.0005099335,0.01284293,0.001868284,0.0002752848,0.005317513,0.0122728,0.001088208,0.01826681,0.0002040109],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9731636,0.0188529,0.0006910216,0.0004645281,0.00008261872,0.0006618446,0.002231897,0.00009951892,0.003752126],"genre_scores_gemma":[0.9884917,0.004685326,0.000561974,0.0004975235,0.0001312426,0.0004484767,0.004009324,0.00001843271,0.001156052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004569717,"threshold_uncertainty_score":0.0241673,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02818014222467983,"score_gpt":0.3017047100186793,"score_spread":0.2735245677939994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}